BioNTech SE
BNTX NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 4, 2026
ET
EPS Est.
-2.40
EPS Actual
-3.70
Revenue Est.
$180.2M
Revenue Actual
$120.6M
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
0.86
Revenue Est.
$1.24B
Company Overview
BioNTech SE (ticker BNTX) is listed on NASDAQ with a market cap of about $29.28B. Its next earnings report (FY2026 Q3) is expected on Nov 3, 2026 (ET), Pre-market, with consensus EPS of 0.86. In the last 15 reported quarters, EPS beat consensus estimates 10 times.
Actual EPS TrendRecently15Term · Mar 27, 2023 → Aug 4, 2026
Mar 27, 2023Range: -3.70 ~ 9.46Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | -2.40 | Below forecast↓-3.70 | $180.2M | $120.6M |
| May 5, 2026 | -- | -2.54 | -2.43 | $207.4M | $136.4M |
| Mar 10, 2026 | -- | -0.22 | Below forecast↓-1.44 | $902.3M | $1.07B |
| Nov 3, 2025 | -- | -1.12 | Above forecast↑-0.14 | $843.7M | $1.78B |
| Aug 4, 2025 | -- | -2.69 | Above forecast↑-1.82 | $177.8M | $307.1M |
| May 5, 2025 | -- | -2.48 | Above forecast↑-1.82 | $215.1M | $200.4M |
| Mar 10, 2025 | -- | 0.46 | Above forecast↑1.15 | $1.18B | $1.23B |
| Nov 4, 2024 | -- | -1.74 | Above forecast↑0.89 | $572.4M | $1.39B |
| Aug 5, 2024 | -- | -2.19 | Below forecast↓-3.62 | $145.4M | $138.4M |
| May 6, 2024 | -- | -1.34 | -1.42 | $479.5M | $201.5M |
| Mar 20, 2024 | -- | 2.62 | Below forecast↓2.05 | $2.03B | $1.63B |
| Nov 6, 2023 | -- | -0.62 | Above forecast↑0.73 | $899.1M | $944.4M |
| Aug 7, 2023 | -- | -0.91 | -0.86 | $685.1M | $182.9M |
| May 8, 2023 | -- | 0.29 | Above forecast↑2.20 | $1.15B | $1.39B |
| Mar 27, 2023 | -- | 8.32 | 9.46 | $3.91B | $4.61B |
Original Filings (SEC)
6-K2026-08-20 ↗
6-K2026-08-04 ↗
6-K2026-08-04 ↗
6-K2026-08-03 ↗
6-K2026-07-29 ↗
6-K2026-06-08 ↗
6-K2026-06-01 ↗
6-K2026-05-22 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
